Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein.

Hitoshi Nishizawa1, Iichiro Shimomura, Ken Kishida

  • 1Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Suita, Japan.

Diabetes
|August 28, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T-cadherin, a major adiponectin binding partner, suppresses ERK signaling in metabolic tissues.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Insulinoma with postprandial hypoglycemia and characteristic expression of GLUT2/GCK/GLP-1R.

The Journal of endocrinology·2026
Same author

Associations among serum soluble T-cadherin levels, serum adiponectin levels, and metabolic risk factors in a Japanese population undergoing medical health checkups.

Endocrine journal·2026
Same author

Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation.

Endocrine journal·2026
Same author

Associations of taste sensitivity with frailty and health-related quality of life in older adults.

The journal of nutrition, health & aging·2026
Same author

Essential role of endothelial T-cadherin in the transcytosis of circulating high-molecular-weight adiponectin to sub-vascular tissues.

Metabolism: clinical and experimental·2026

Androgens, like testosterone, lower adiponectin (a protein with anti-diabetic and anti-atherogenic effects) levels in men. This reduction in adiponectin may increase risks for insulin resistance and atherosclerosis.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Cardiovascular Science

Background:

  • Adiponectin is an adipose-specific protein with known antidiabetic and antiatherogenic effects.
  • Understanding factors regulating adiponectin is crucial for metabolic and cardiovascular health.
  • Sex hormones are potential modulators of adiponectin production and function.

Purpose of the Study:

  • To investigate the influence of sex hormones on adiponectin regulation.
  • To determine the relationship between androgen levels and plasma adiponectin concentrations.
  • To explore the impact of androgen-modulated adiponectin on insulin sensitivity.

Main Methods:

  • Comparative analysis of plasma adiponectin levels in men and women.
  • In vivo studies in mice involving ovariectomy, castration, and testosterone treatment.

Related Experiment Videos

  • In vitro studies using 3T3-L1 adipocytes to assess adiponectin secretion.
  • Pulse-chase experiments to track adiponectin secretion dynamics.

    • Main Results:

    • Plasma adiponectin was significantly lower in men compared to women.
    • Ovariectomy did not affect adiponectin levels in mice, but castration increased them.
    • Testosterone administration reduced plasma adiponectin in both intact and castrated mice.
    • Testosterone decreased adiponectin secretion from 3T3-L1 adipocytes.
    • Increased adiponectin following castration correlated with improved insulin sensitivity.

    Conclusions:

    • Androgens significantly decrease plasma adiponectin levels.
    • Androgen-induced hypoadiponectinemia may contribute to increased insulin resistance and atherosclerosis risk in men.
    • These findings highlight a potential mechanism linking sex hormones, adiponectin, and metabolic/cardiovascular disease.